Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic
Our findings indicate no significant changes in ESKD incidence in South Korea during the pandemic. However, there were shifts in modality distribution, with decreased PD and increased HD cases. Notably, HD cases showed a significant reduction in hospital admissions and length of stay. The healthcare system demonstrated stability during the pandemic, with minimal disruptions in ESKD care.
Authors
- Inwhee Park (ORCID: https://orcid.org/0000-0002-9912-5393)
- Hankil Lee (ORCID: https://orcid.org/0000-0002-7780-159X)
- Min Jeong Lee (ORCID: https://orcid.org/0000-0002-2611-7333)
- Ah‐Young Kim (ORCID: https://orcid.org/0000-0001-7264-7602)
- Heejung Choi
Institutions
- Ajou University (KR)
Publication Details
- Journal
- The Korean Journal of Internal Medicine
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3904/kjim.2024.052
- Citations
- 4
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Ministry of Food and Drug Safety